Atassi G - Search Results

1

A characterization of the activity of alpha-1,3,5-triglycidyl-s-triazinetrione, a novel antineoplastic compound.

Spreafico F, Atassi G, Filippeschi S, Malfiore C, Noseda S, Boschetti D. Spreafico F, et al. Among authors: atassi g. Cancer Chemother Pharmacol. 1980;5(2):103-8. doi: 10.1007/BF00435412. Cancer Chemother Pharmacol. 1980. PMID: 7471313

2

Antitumoral effect in mice of a new triepoxyde derivative: 1, 3, 5-triglycidyl-s-triazinetrione (NSC 296934).

Atassi G, Spreafico F, Dumont P, Nayer P, Klastersky J. Atassi G, et al. Eur J Cancer (1965). 1980 Dec;16(12):1561-7. doi: 10.1016/0014-2964(80)90029-8. Eur J Cancer (1965). 1980. PMID: 7227431 No abstract available.

3

Characterization of the anti-tumour activity against solid tumours of a new nitrosoureido sugar: Cy 233.

Atassi G, Dumont P, Gosse C, Fournier JP, Gouyette A, Roger P. Atassi G, et al. Cancer Chemother Pharmacol. 1989;25(3):205-9. doi: 10.1007/BF00689584. Cancer Chemother Pharmacol. 1989. PMID: 2598412

4

Characterization of the activity of alpha/beta-triglycidylurazol (TGU; NSC-332488): a new antineoplastic compound.

Atassi G, Dumont P, Vanhaelen C. Atassi G, et al. Eur J Cancer Clin Oncol. 1984 Sep;20(9):1187-91. doi: 10.1016/0277-5379(84)90128-7. Eur J Cancer Clin Oncol. 1984. PMID: 6541138

5

Development and characterization of a new murine renal tumor model. Chemotherapeutic results.

Vandendris M, Dumont P, Heimann R, Atassi G. Vandendris M, et al. Among authors: atassi g. Cancer Chemother Pharmacol. 1983;11(3):182-7. doi: 10.1007/BF00254201. Cancer Chemother Pharmacol. 1983. PMID: 6640825

6

In vivo antitumor activity of S 16020-2, a new olivacine derivative.

Guilbaud N, Kraus-Berthier L, Saint-Dizier D, Rouillon MH, Jan M, Burbridge M, Visalli M, Bisagni E, Pierré A, Atassi G. Guilbaud N, et al. Among authors: atassi g. Cancer Chemother Pharmacol. 1996;38(6):513-21. doi: 10.1007/s002800050520. Cancer Chemother Pharmacol. 1996. PMID: 8823492

7

Absence of antitumor activity of ORG 5895, a 11 beta-aziridinylmethyl derivative of estradiol, on the MXT mammary tumor and the P388 leukemia.

Devleeschouwer N, Leclercq G, Danguy A, Atassi G. Devleeschouwer N, et al. Among authors: atassi g. Cancer Chemother Pharmacol. 1982;8(3):315-6. doi: 10.1007/BF00254057. Cancer Chemother Pharmacol. 1982. PMID: 7127663 No abstract available.

8

Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.

Kraus-Berthier L, Guilbaud N, Léonce S, Parker T, Genissel P, Guillonneau C, Goldstein S, Atassi G, Pierré A. Kraus-Berthier L, et al. Among authors: atassi g. Cancer Chemother Pharmacol. 2002 Aug;50(2):95-103. doi: 10.1007/s00280-002-0481-z. Epub 2002 Jun 25. Cancer Chemother Pharmacol. 2002. PMID: 12172972

9

In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model.

Cros S, Guilbaud N, Berlion M, Dunn T, Regnier G, Dhainaut A, Atassi G, Bizzari JP. Cros S, et al. Among authors: atassi g. Cancer Chemother Pharmacol. 1992;30(6):491-4. doi: 10.1007/BF00685604. Cancer Chemother Pharmacol. 1992. PMID: 1394807

10

Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3 H)-one (mitozolomide), a novel broad-spectrum agent.

Hickman JA, Stevens MF, Gibson NW, Langdon SP, Fizames C, Lavelle F, Atassi G, Lunt E, Tilson RM. Hickman JA, et al. Among authors: atassi g. Cancer Res. 1985 Jul;45(7):3008-13. Cancer Res. 1985. PMID: 4005840

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters